DEC 07, 2021 9:00 AM PST

Enhanced ACE2 humanized rodent models to make COVID-19 research more translatable

Sponsored by: Envigo
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  December 7, 2021
Time: 9:00am (PST),  12:00pm (EST)
 
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 228 million individuals and claimed 4.69 million lives as of Sept 21, 2021. SARS-CoV-2 infects host cells by the binding of its spike protein to the cellular surface protein angiotensin-converting enzyme 2 (ACE2). Unlike human ACE2, mouse and rat Ace2 proteins cannot efficiently mediate the SARS-CoV-2 infection. Therefore, wild type mice and rats cannot be used for modeling the disease. Currently, most widely used mouse models for COVID-19 research are random transgenic models that artificially express human ACE2 under the control of a non-specific promoter. While most of these mice show some COVID-19 phenotypes, none of those transgenic models fully recapitulate the disease course observed in COVID-19 patients. This is because the transgene promoter, integration site, and copy number in those models all differ from those of mouse Ace2 gene, and furthermore, the mouse endogenous Ace2 is still expressed in those models. In this his webinar, Dr.Zhao will discuss current available hACE2 models including a couple of Envigo's new hACE2 knockin mouse and rat models.
 
Learning Objectives
  • Review current commercial animal models for COVID-19 research
  • Explore differences between hACE2 transgenic models and hACE2 knockin models
  • Gain understanding of the characterization of Envigo's hACE2 mouse and rat models
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
NOV 01, 2022 10:00 AM PDT
NOV 01, 2022 10:00 AM PDT
Date: November 01, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 6:00pm (CET) Our laboratory developed the Pig-a gene mutation assay as a means to simply and reliably evaluate the potential mutage...
OCT 11, 2022 8:00 AM PDT
C.E. CREDITS
OCT 11, 2022 8:00 AM PDT
Date: October 11, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Multiomic profiling of cell populations at single-cell resolution is revolutionizing scientists’ understanding o...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
NOV 09, 2022 8:00 AM PST
C.E. CREDITS
NOV 09, 2022 8:00 AM PST
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
Loading Comments...
Show Resources